7th accp conference on antithrombotic and thrombolytic therapy
Download
1 / 25

7th ACCP Conference on Antithrombotic and Thrombolytic Therapy: - PowerPoint PPT Presentation


  • 131 Views
  • Uploaded on

7th ACCP Conference on Antithrombotic and Thrombolytic Therapy:. Evidence-Based Guidelines. Grade 1 Recommendations. RCT = randomized controlled trial. Grade 2 Recommendations. RCT = randomized controlled trial. Treatment of Venous Thromboembolic Disease.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' 7th ACCP Conference on Antithrombotic and Thrombolytic Therapy:' - peers


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
7th accp conference on antithrombotic and thrombolytic therapy

7th ACCP Conference on Antithrombotic and Thrombolytic Therapy:

Evidence-Based Guidelines


Grade 1 recommendations
Grade 1 Recommendations Therapy:

RCT = randomized controlled trial


Grade 2 recommendations
Grade 2 Recommendations Therapy:

RCT = randomized controlled trial



Initial therapy for acute dvt of the leg
Initial Therapy for Acute DVT of the Leg Therapy:

  • We recommend that patients receive anticoagulants as soon as the diagnosis of DVT is confirmed

  • Interim treatment should be started if suspicion is high and confirmation is delayed








Long term therapy for dvt of the leg continued
Long-term Therapy for DVT of the Leg, continued Therapy:

*Established LMWH regimens for long-term treatment: dalteparin, 200 IU/kg body weight qd for 1 month, then 150 IU/kg qd; or tinzaparin, 175 IU/kg body weight SC qd.






Initial therapy for pe additional recommendations
Initial Therapy for PE: Therapy:Additional Recommendations


Initial therapy for pe additional recommendations continued
Initial Therapy for PE: Therapy:Additional Recommendations, continued



Long term therapy for pe vka therapy continued
Long-Term Therapy for PE: Therapy:VKA Therapy, continued


Long term therapy for pe vka therapy continued1
Long-Term Therapy for PE: Therapy:VKA Therapy, continued






ad